The Report Guru

The industry is consolidated in nature with the presence of many local, regional, and global players. Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), and Unilever plc (U.K.) were the major players in this market. The companies are mainly focusing on product launches, agreements, and expansions to strengthen their product offerings and establish a strong geographical foothold. According to recent research report the global  oral care market  is projected to reach USD 53.97 billion by 2022 from USD 43.31 billion in 2017, at a CAGR of 4.5%. Colgate-Palmolive Company (U.S.) dominated the global oral care market in 2016. The company significantly focuses on product innovation, product enhancement, and product launches; it invested USD 289 million for R&D activities in 2016. The company launched two new products, Colgate Optic White Toothbrush + Whitening Pen (the toothbrush with a built-in whitening pen) and Pain Out (a tooth pain relief product) in 2014

According to research report the global  contrast media market  is expected to reach USD 8.68 billion by 2027 from USD 4.56 billion in 2018, at a CAGR of 3.9%. The major factors driving the growth of the contrast media/contrast agents market include increasing number of research and funding activities for research of contrast agents and their applications. Read More :  https://www.marketsandmarkets.com/PressReleases/contrast-media.asp   By type, the iodinated contrast media segment is expected to account for the largest share of the market in 2017 On the basis of type, the contrast media/contrast agents market is segmented into iodinated contrast media, gadolinium-based contrast media, barium-based contrast media, and microbubble contrast media. In 2017, the iodinated contrast media segment is estimated to account for the largest share of the contrast media/contrast agents market, by type. However, the microbubble contrast media segment is expected to grow at the highest CAGR during t

According to research report the global  Genome Engineering Market  is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022. Lucrative North America markets to offer significant growth opportunities for the genome editing market in the coming years. This can be attributed to the development of gene therapy, increasing use of genetically modified (GM) crops, and rising availability of research grants and funding in the U.S., and government initiatives and the intensification of genomics R&D in Canada.  Download Brochure :  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231037000 Companies in the U.S. are developing their own gene therapies. For instance, in May 2015, Bluebird Bio began seeking approval for LentiGlobin, a gene therapy for beta-thalassemia, a blood disorder. These treatments are expected to be the first gene therapies approved in the U.S. Cold Genesys, Amgen, VBL Therapeutics, Adva

According to the research report the coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. The coronary stent market is witnessing significant growth across the globe owing to factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of coronary artery disease (CAD), increasing demand for minimally invasive procedures, and rising geriatric population. Moreover, development of bioresorbable vascular scaffold (BVS) and expansion in emerging markets provide significant growth opportunities in the market . Download Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=77411272 Key players in this market are pursuing strategies such as product approvals; product launches and enhancements; partnerships, collaborations, and contracts; expansions; acquisitions; and certifications.   The coronary stent market is segment

According to the new market research report  Single-use Bioreactors Market  is expected to grow at a CAGR of 21.9% from 2017 to 2022, to reach 2,685.1 Million by 2022 from USD 997.6 Million in 2017. The single-use bioreactors market is segmented on the basis of product type, cell type, technology, application, end user, and region. Based on product type, the market is segmented into monoclonal antibodies, vaccines, gene-modified cells, recombinant proteins, stem cells, and other products (growth factors, interferons, and antisense DNA & RNA). Among the above mentioned product segments, the stem cells segment is estimated to witness the highest growth during the forecast period. The high growth in this segment can be attributed to advantages such as reduced medium consumption, ease of use, and the ability to monitor process parameters and cell health.  Research & Development is expected to be the Fastest-growing Application Segment in the Single-use Bioreactors Market Speak to

According to research report the global  in vitro toxicology testing market  is projected to reach USD 8.74 billion by 2022 from USD 6.34 billion in 2017, at a CAGR of 6.6% during the forecast period. Factors such as opposition to animal testing, advent new and promising technologies, and increasing R&D expenditure to detect toxicity at an early stage are driving the growth of this market. In this report, the market is segmented on the basis of products & services, toxicity endpoints and tests, industry, technology, method, and region. On the basis of product, the in vitro toxicology testing market is segmented into assays, services, and reagents. The services segment is projected to grow at the fastest rate owing to the rising trend of outsourcing of in vitro toxicity tests by small and medium-sized pharmaceutical and cosmetics companies due to lack of infrastructure and expertise and the difficulty in procuring of reagents required for every target.  Speak to Analyst:  https

According to research report the report Medical Power Supply Market is expected to reach USD 1,218.6 Million by 2022 from USD 885.3 Million in 2017, at a CAGR of 6.6% from 2017 to 2022. The major factors driving the growth of this market can be attributed to the growth in funding and infrastructure development, advancements in medical power supply products, and rising trend of home healthcare. While product launch and enhancements remain at the center of the strategic growth initiatives pursued by a majority of the key players in the global medical power supply market, players are also focusing on increasing their presence in the high-growth markets through agreements, expansions, and acquisitions. XP Power (Singapore), Spellman High Voltage Electronics Corporation (U.S.), Powerbox International AB (Sweden), Meanwell Enterprises (Taiwan), Handy and Harman (U.S.), Globtek (U.S.), FRIWO Gerätebau (Germany), Delta Electronics (Taiwan), and Astrodyne TDI Power Supplies and EMI Filters

According to research report the  sinus dilation devices market  is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of this market is mainly driven by the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries. Read More:  https://www.marketsandmarkets.com/PressReleases/sinus-dilation-device.asp Benefits of balloon sinuplasty / sinus dilation over conventional sinus surgeries to drive the growth of sinus dilation devices market Hospitals Hospitals is one of the patient care settings where sinus dilation devices are extensively used. This segment holds the largest market share due to high number of outpatient sinus dilation procedures, the advantages of having integrated healthcare facilities, the availability of technologi